National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting, 30474 [05-10534]
Download as PDF
<![CDATA[
30474
Federal Register / Vol. 70, No. 101 / Thursday, May 26, 2005 / Notices
400C, 6120 Executive Blvd., Bethesda, MD
20892, 301–496–8683.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.173, Biological Research
Related to Deafness and Communicative
Disorders, National Institutes of Health, HHS)
Dated: May 18, 2009.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–10532 Filed 5–25–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
National Library of Medicine; Notice of
Meeting
Office of Biotechnology Activities,
Office of the Director; Notice of
Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the sixth meeting of
the Commission on Systemic
Interoperability.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The mission of the Commission on
Systemic Interoperability is to submit a
report to the Secretary of Health and
Human Services and to Congress on a
comprehensive strategy for the adoption
and implementation of health care
information technology standards that
includes a timeline and prioritization
for such adoption and implementation.
In developing that strategy, the
Commission will consider: (1) The costs
and benefits of the standards, both
financial impact and quality
improvement; (2) The current demand
on industry resources to implement the
Medicare Prescription Drug,
Improvement, and Modernization Act of
2003 and other electronic standards,
including HIPAA standards; and (3) The
most cost-effective and efficient means
for industry to implement the standards.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel, NIBIB Training
Review.
Date: June 29–30, 2005.
Time: June 29, 2005, 6 p.m. to 9 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Time: June 30, 2005, 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Jabreel Boyd, Office of
Scientific Review, National Institute of
Biomedical Imaging and Bioengineering,
Suite 920, Bethesda, MD 20892, 301–496–
8633, boydjab@od.nih.gov.
Name of Committee: Commission on
Systemic Interoperability.
Date: June 14, 2005.
Time: 8 a.m. to 4 p.m.
Agenda: Healthcare Information
Technology Standards.
Place: Hubert H. Humphrey Building,
Room 800, 200 Independence Avenue,
Washington, DC 20201.
Contact Person: Ms. Dana Haza, Director,
Commission on Systemic Interoperability,
National Library of Medicine, National
Institutes of Health, Building 38, Room 2N21,
Bethesda, MD 20894. 301–594–7520.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The comments should include
the name, address, telephone number and,
when applicable, the business or professional
affiliation of the interested person.
Dated: May 18, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–10534 Filed 5–25–05; 8:45 am]
Dated: May 19, 2005.
Anna Snouffer,
Deputy Director, Officer of Federal Advisory
Committee Policy.
[FR Doc. 05–10517 Filed 5–25–05; 8:45 am]
BILLING CODE 4140–01–M
BILLING CODE 4140–01–M
VerDate jul<14>2003
19:11 May 25, 2005
Jkt 205001
PO 00000
Frm 00065
Fmt 4703
Sfmt 4703
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the inaugural meeting
of the National Science Advisory Board
for Biosecurity (NSABB).
Under authority 42 U.S.C. 217a,
section 222 of the Public Health Service
Act, as amended, the Department of
Health and Human Services established
NSABB to provide advice, guidance and
leadership regarding federal oversight of
usual-use research, defined as biological
research with legitimate scientific
purposes that could be misused to pose
a biological threat to public health
and/or national security.
The meeting will be open to the
public as indicated below. Preregistration is recommended due to
space limitations. Persons planning to
attend should register online at https://
www.biosecurityboard.gov/meeting.asp
or by calling The Hill Group (Heather
Thompson) at 301–897–2789, ext. 132.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
indicate these requirements upon
registration.
Name of Committee: National Science
Advisory Board for Biosecurity.
Date: June 30–July 1, 2005.
Open: 8 a.m. to 3 p.m.
Agenda: (1) Presentation and discussions
on criteria for defining dual-use research in
the life sciences and the role of a code of
conduct for the life sciences; (2) discuss
issues raised by dual-use research with
respect to scientific communication, genome
synthesis, and international perspectives; (3)
public comments; (4) and other business of
the committee.
Place: Hyatt Regency Bethesda, 7400
Wisconsin Avenue, Bethesda, Maryland.
Contact Person: Thomas Holohan, M.D.,
NSABB Executive Director, 6705 Rockledge
Drive, Bethesda, Maryland 20892. (301) 496–
9838.
This meeting will also be webcast. The
draft meeting agenda and other information
about NSABB, including information about
access to the webcast and pre-registration,
will be available at https://
www.biosecurityboard.gov.
Any member of the public interested in
presenting oral comments at the meeting may
notify the Contact Person listed on this notice
at least 10 days in advance of the meeting.
Interested individuals and representatives of
an organization may submit a letter of intent,
a brief description of the organization
E:\FR\FM\26MYN1.SGM
26MYN1
]]>Agencies
[Federal Register Volume 70, Number 101 (Thursday, May 26, 2005)]
[Notices]
[Page 30474]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-10534]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical Imaging and Bioengineering;
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Biomedical Imaging and
Bioengineering Special Emphasis Panel, NIBIB Training Review.
Date: June 29-30, 2005.
Time: June 29, 2005, 6 p.m. to 9 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Time: June 30, 2005, 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Jabreel Boyd, Office of Scientific Review,
National Institute of Biomedical Imaging and Bioengineering, Suite
920, Bethesda, MD 20892, 301-496-8633, boydjab@od.nih.gov.
Dated: May 18, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-10534 Filed 5-25-05; 8:45 am]
BILLING CODE 4140-01-M
